Evidence map›Paper›PMID 42207008›Full record

ArticleScience progress

MCAMamba: A multimodal method with bidirectional cross-attention and state space model for cancer survival prediction.

Haiyan Cui, Xiaofei Liu, Weiping Ding, Weixing Wang

Abstract read
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Haiyan CuiFaculty of Data Science, City University of Macau, China.ORCID 0009-0001-1599-6221
Xiaofei LiuSchool of Artificial Intelligence, Guangdong Open University, Guangzhou, China.
Weiping DingSchool of Artificial Intelligence and Computer Science, Nantong University, Nantong, China.
Weixing WangSchool of Artificial Intelligence, Guangdong Open University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer survival prediction is crucial for clinical decision-making and personalized treatment planning. The joint analysis of pathological images and genomic profiles provides complementary information at both histological and molecular levels, offering a more comprehensive foundation for patient prognosis assessment. However, existing multimodal survival prediction methods face two major challenges: (1) How to efficiently capture global dependencies in high-dimensional, long sequence features while maintaining linear complexity? (2) How to fully preserve and utilize the inherent valuable information of each modality while achieving cross-modal interaction? To address these challenges, we propose MCAMamba, a multimodal method with bidirectional cross-attention and a state space model for cancer survival prediction. This method employs a parallel encoder-decoder architecture, leveraging Mamba's efficient long sequence modeling capabilities to capture global dependencies and discriminative features within each modality. Meanwhile, a Bidirectional Cross-Attention module is integrated into the framework to achieve semantic alignment and complementary information exchange across modalities, enhancing the prediction of patient survival risk. Experimental results on four public TCGA cancer datasets (BLCA, BRCA, UCEC, and LUAD) demonstrate that MCAMamba significantly outperforms existing methods in predictive performance. The c-index improves by 2.47%-17.9%, validating the superior performance of the method in multimodal cancer survival prediction.

Indexed as

NeoplasmsAlgorithmsHumansPrognosisSurvival Analysisbidirectional cross-attentionMambamultimodal learningsurvival predictionwhole slide image

Identifiers

PMID42207008
PMCPMC13219868

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.